Giant drug deal: Bristol-Myers Squibb buying Celgene for $74 billion
January 03, 2019 at 09:32 AM EST
Bristol-Myers Squibb said the deal will strengthen its cancer and inflammatory disease drug products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|